Bertolini F - Search Results

1

Molecular and cellular biomarkers for angiogenesis in clinical oncology.

Bertolini F, Mancuso P, Shaked Y, Kerbel RS. Bertolini F, et al. Drug Discov Today. 2007 Oct;12(19-20):806-12. doi: 10.1016/j.drudis.2007.08.011. Epub 2007 Sep 27. Drug Discov Today. 2007. PMID: 17933680 Review.

2

CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma.

Bertolini F, Dell'Agnola C, Mancuso P, Rabascio C, Burlini A, Monestiroli S, Gobbi A, Pruneri G, Martinelli G. Bertolini F, et al. Cancer Res. 2002 Jun 1;62(11):3106-12. Cancer Res. 2002. PMID: 12036921

3

In vitro and in vivo hematopoietic potential of human stem cells residing in muscle tissue.

Dell'Agnola C, Rabascio C, Mancuso P, Capillo M, Pruneri G, Gobbi A, Minucci S, Ronzoni S, Volorio S, Calabrese L, Tradati N, Martinelli G, Shultz L, Bertolini F. Dell'Agnola C, et al. Among authors: bertolini f. Exp Hematol. 2002 Aug;30(8):905-14. doi: 10.1016/s0301-472x(02)00866-4. Exp Hematol. 2002. PMID: 12160842 Free article.

4

Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitors.

Capillo M, Mancuso P, Gobbi A, Monestiroli S, Pruneri G, Dell'Agnola C, Martinelli G, Shultz L, Bertolini F. Capillo M, et al. Among authors: bertolini f. Clin Cancer Res. 2003 Jan;9(1):377-82. Clin Cancer Res. 2003. PMID: 12538491

5

Angiogenesis occurs in hairy cell leukaemia (HCL) and in NOD/SCID mice transplanted with the HCL line Bonna-12.

Pruneri G, Bertolini F, Baldini L, Valentini S, Goldaniga M, Soligo D, Carboni N, Viale G, Lambertenghi-Deliliers G. Pruneri G, et al. Among authors: bertolini f. Br J Haematol. 2003 Feb;120(4):695-8. doi: 10.1046/j.1365-2141.2003.04133.x. Br J Haematol. 2003. PMID: 12588359 Free article.

6

Circulating endothelial cells as a novel marker of angiogenesis.

Mancuso P, Calleri A, Cassi C, Gobbi A, Capillo M, Pruneri G, Martinelli G, Bertolini F. Mancuso P, et al. Among authors: bertolini f. Adv Exp Med Biol. 2003;522:83-97. doi: 10.1007/978-1-4615-0169-5_9. Adv Exp Med Biol. 2003. PMID: 12674213

7

Stroma cells: a novel target of herceptin activity.

Corsini C, Mancuso P, Paul S, Burlini A, Martinelli G, Pruneri G, Bertolini F. Corsini C, et al. Among authors: bertolini f. Clin Cancer Res. 2003 May;9(5):1820-5. Clin Cancer Res. 2003. PMID: 12738740

8

Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells.

Bertolini F, Paul S, Mancuso P, Monestiroli S, Gobbi A, Shaked Y, Kerbel RS. Bertolini F, et al. Cancer Res. 2003 Aug 1;63(15):4342-6. Cancer Res. 2003. PMID: 12907602

9

Chlorambucil in combination with induction and maintenance rituximab is feasible and active in indolent non-Hodgkin's lymphoma.

Martinelli G, Laszlo D, Bertolini F, Pastano R, Mancuso P, Calleri A, Vanazzi A, Santoro P, Cavalli F, Zucca E. Martinelli G, et al. Among authors: bertolini f. Br J Haematol. 2003 Oct;123(2):271-7. doi: 10.1046/j.1365-2141.2003.04586.x. Br J Haematol. 2003. PMID: 14531908 Free article. Clinical Trial.

10

Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells.

Rabascio C, Muratori E, Mancuso P, Calleri A, Raia V, Foutz T, Cinieri S, Veronesi G, Pruneri G, Lampertico P, Iavarone M, Martinelli G, Goldhirsch A, Bertolini F. Rabascio C, et al. Among authors: bertolini f. Cancer Res. 2004 Jun 15;64(12):4373-7. doi: 10.1158/0008-5472.CAN-04-0265. Cancer Res. 2004. PMID: 15205354

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

532 results

Search Page